Overview
This is the only EU Forum designed for QPPVs by QPPVs, now in its 9th year and ever growing. This year’s objectives, as shown below, build on past successes and have been shaped by valuable feedback provided by participants.
Download Programme
- Hear the latest updates and hot topics relating to the role of the QPPV
- Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of QPPV
- Network with colleagues and meet regulators
- Learn from and share experience and ideas with like-minded and friendly QPPVs in a professional environment
- Take away practical hints and tips
- Better understand regulatory and inspectorate expectations of the QPPV
- Identify the expanded expectations of the role in the context of the new regulatory framework and transparency initiatives
- Be reassured ("I am not missing anything"), reality check
- Examine current areas of real challenge
Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement from key Regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This 9th Forum aims to continue to attract such key speakers and encourage open debate.
Program Committee
-
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Margaret Anne Walters Deputy EU Qualified Person for Pharmacovigilance
Merck, Sharp & Dohme Ltd, United Kingdom -
Barbara De Bernardi, MD EUQPPV Vice President - Head of Global QPPV Office
Pfizer S.r.l., Italy -
Peter De Veene, MD GQPPV
MSD Belgium, Belgium -
Brian Edwards, DrMed Vice President
International Society of Pharmacovigilance, United Kingdom -
Shelley Gandhi, MSc Strategic Advisor, Pharmacovigilance and Drug Safety
NDA Group, United Kingdom -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Winrich Rauschning, DrMed, MD, MBA QPPV
Biolitec Pharma, Germany -
Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom -
Doris Irene Stenver, MD, MPA Independent Pharmacovigilance Adviser
Unique Advice, Denmark
Have an account?